Research and Treatment

Research & Treatment

For Christine Orr, the trigger for starting prophylaxis wasn’t just one thing. It was everything. Orr’s son, John, diagnosed with...
Update, October 22, 2015: The US Food and Drug Administration (FDA) issued a warning that AbbVie’s Viekira Pak ® and...
An October 2011 study revealed a novel characteristic of HIV—it can replicate, or make new copies of itself in macrophages...
The release of two new oral medications, Incivek TM and ­Victrelis TM, in May 2011 marks another significant advance in...
The marketing terms “new and improved” and “longer lasting” are not limited to the latest brand of chewing gum. They...
The bleeding disorders community is in a unique period of drug development. Almost every pharmaceutical company currently producing factor products...
The shoulder is a versatile joint. It allows you to swing a golf club, throw a curve ball and paint...
HemAware is conducting a series of interviews with researchers who have received awards from the National Hemophilia Foundation (NHF) to...
HemAware is conducting a series of interviews with researchers who have received awards from the National Hemophilia Foundation (NHF) to...
HemAware is conducting a series of interviews with researchers who have received awards to pursue their research interests. This interview...
HemAware is conducting a series of interviews with researchers who have received awards from the National Hemophilia Foundation (NHF) to...
Chat Icon
Need Info? Ask NBDF!
Contact HANDI, NBDF's resource center for additional information on bleeding disorders.